基于网络药理学探究淡豆豉对缺血性卒中的作用机制
To Investigate the Mechanism of Sojae Semen Praeparatum Sauce on Ischemic Stroke Based on Network Pharmacology
DOI: 10.12677/TCM.2023.122061, PDF,    科研立项经费支持
作者: 刘林潇, 全德森, 杜京晏, 彭景熠, 蔡 琨*:贵州中医药大学,贵州 贵阳
关键词: 缺血性卒中网络药理学淡豆豉Ischemic Stroke Network Pharmacology Sojae Semen Praeparatum
摘要: 目的:通过网络药理学探讨淡豆豉对缺血性卒中(Ischemic stroke, IS)的作用机制。方法:通过TCMSP数据库和Uniprot对淡豆豉的有效成分和靶点进行筛选;使用OMIM、DisGeNET、GeneCards数据库收集IS相关靶点。将IS相关靶点与淡豆豉有效成分靶点的交集作为淡豆豉防治IS的潜在作用靶点,借助STRING数据库和Cytoscape3.9.1软件的“CytoNCA”绘制PPI图,利用DAVID 2021数据库和微生信平台进行GO和KEGG可视化分析。结果:筛选出淡豆豉中含有5个活性成分及34个AS潜在作用靶点,其中蛋白互作显示ESR1、PPARG、GSK3B等是淡豆豉防治IS的关键靶点;KEGG显示淡豆豉主要通过IL-17信号通路来发挥防治AS的作用。结论:本研究初步探讨了淡豆豉治疗IS,可能是通过作用于ESR1、PPARG、GSK3B等关键靶点和IL-17信号通路以及其他疾病,进而发挥治疗缺血性卒中的作用。
Abstract: Objective: To investigate the mechanism of Sojae Semen Praeparatum on ischemic stroke (IS) by network pharmacology. Methods: The active ingredients and targets of Sojae Semen Praeparatum were screened by TCMSP database and Uniprot, and the IS-related targets were collected by OMIM, DisGeNET and GeneCards databases. The intersection of IS-related targets and active ingredient targets of Sojae Semen Praeparatum was used as a potential target for the prevention and treatment of IS by Sojae Semen Praeparatum. PPI maps were drawn with the help of STRING database and “CytoNCA” of Cytoscape3.9.1 software, and GO and KEGG visualization analyses were performed using DAVID 2021 database and Microbiology Information platform. Results: Sojae Semen Praeparatum contained 5 active components and 34 potential targets of AS, of which ESR1, PPARG and GSK3B were the key targets of Sojae Semen Praeparatum to prevent and treat IS, and KEGG showed that Sojae Semen Praeparatum mainly played a role in preventing and treating AS through IL-17 signaling pathway. Conclusion: This study preliminarily investigated the therapeutic effect of Sojae Semen Praeparatum on IS, which may play a role in the treatment of ischemic stroke by acting on key targets such as ESR1, PPARG, GSK3B, IL-17 signaling pathway and other diseases.
文章引用:刘林潇, 全德森, 杜京晏, 彭景熠, 蔡琨. 基于网络药理学探究淡豆豉对缺血性卒中的作用机制[J]. 中医学, 2023, 12(2): 401-410. https://doi.org/10.12677/TCM.2023.122061

参考文献

[1] GBD 2019 Stroke Collaborators (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820. [Google Scholar] [CrossRef
[2] DeMars, K.M., McCrea, A.O., Yang, C., et al. (2017) Abstract TP274: Activation of the Prostaglandin E2 Receptor EP4 Reduces Blood-Brain Barrier Damage in a Rat Model of Ischemic Stroke. Stroke, 48, Article No. ATP274. [Google Scholar] [CrossRef
[3] Jayaraj, R.L., Azimullah, S., Beiram, R., Jalal, F.Y. and Rosenberg, G.A. (2019) Neuroinflammation: Friend and Foe for Ischemic Stroke. Journal of Neuroinflammation, 16, Article No. 142. [Google Scholar] [CrossRef] [PubMed]
[4] Feske, S.K. (2021) Ischemic Stroke. The American Journal of Medicine, 134, 1457-1464. [Google Scholar] [CrossRef] [PubMed]
[5] 关水清, 周改莲, 周媛, 等. 淡豆豉的本草考证及现代研究概况[J]. 中药材, 2020, 43(9): 2296-2303.
[6] (梁)陶弘景, 撰, 尚志钧, 辑校. 名医别录[M]. 北京: 人民卫生出版社, 1986.
[7] 周秋丽, 王涛, 王本祥. 现代中药基础研究与临床[M]. 天津: 天津科技翻译出版社, 2012.
[8] Ru, J., Li, P., Wang, J., et al. (2014) TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[9] The UniProt Consortium (2020) UniProt: The Universal Protein Knowledgebase in 2021. Nucleic Acids Research, 49, D480-D489. https://academic.oup.com/nar/article/49/D1/D480/6006196?login=false
[10] Piñero, J., Saüch, J., Sanz, F. and Furlong, L.I. (2021) The DisGeNET Cytoscape App: Exploring and Visualizing Disease Genomics Data. Computational and Structural Biotechnology Journal, 19, 2960-2967. [Google Scholar] [CrossRef] [PubMed]
[11] Safran, M., Rosen, N., Twik, M., et al. (2021) The GeneCards Suite. In: Abugessaisa, I. and Kasukawa, T., Eds., Practical Guide to Life Science Databases, Springer, Singapore, 27-56. [Google Scholar] [CrossRef
[12] Sherman, B.T., Hao, M., Qiu, J., et al. (2022) DAVID: A Web Server for Functional Enrichment Analysis and Functional Annotation of Gene Lists (2021 update). Nucleic Acids Research, 50, W216-W221. [Google Scholar] [CrossRef] [PubMed]
[13] Paul, A.L. (2012) A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke. Current Pharmaceutical Design, 18, 3694-3703. [Google Scholar] [CrossRef] [PubMed]
[14] Mnafgui, K., Ghazouani, L., Hajji, R., et al. (2021) Oleu-ropein Protects Against Cerebral Ischemia Injury in Rats: Molecular Docking, Biochemical and Histological Findings. Neurochemical Research, 46, 2131-2142. [Google Scholar] [CrossRef] [PubMed]
[15] Clegg, D., Hevener, A.L., Moreau, K.L., et al. (2017) Sex Hormones and Cardiometabolic Health: Role of Estrogen and Estrogen Receptors. Endocrinology, 158, 1095-1105. [Google Scholar] [CrossRef] [PubMed]
[16] Iorga, A., Cunningham, C.M., Moazeni, S., et al. (2017) The Protective Role of Estrogen and Estrogen Receptors in Cardiovascular Disease and the Controversial Use of Estrogen Therapy. Biology of Sex Differences, 8, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[17] Pelekanou, V., Kampa, M., Kiagiadaki, F., et al. (2016) Estrogen Anti-Inflammatory Activity on Human Monocytes Is Mediated through Cross-Talk between Estrogen Receptor ERα36 and GPR30/GPER1. Journal of Leukocyte Biology, 99, 333-347. [Google Scholar] [CrossRef
[18] Somani, Y.B., Pawelczyk, J.A., De Souza, M.J., Kris-Etherton, P.M. and Proctor, D.N. (2019) Aging Women and Their Endothelium: Probing the Relative Role of Estrogen on Vasodilator Function. American Journal of Physiology-Heart and Circulatory Physiology, 317, H395-H404. [Google Scholar] [CrossRef] [PubMed]
[19] Fu, R., Shen, Y. and Zheng, J. (2019) Association between Common Genetic Variants in ESR1 and Stroke Risk: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 28, Article ID: 104355. [Google Scholar] [CrossRef] [PubMed]
[20] Verrier, E., Wang, L., Wadham, C., et al. (2004) PPARγ Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol—Protein Kinase C Signaling Pathway. Circulation Research, 94, 1515-1522. [Google Scholar] [CrossRef
[21] Hsieh, F.-I., Lo, W.-C., Lin, H.-J., et al. (2009) Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke. Diabetes Care, 32, 2033-2035. [Google Scholar] [CrossRef] [PubMed]
[22] Jope, R.S., Yuskaitis, C.J. and Beurel, E. (2007) Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics. Neurochemical Research, 32, 577-595. [Google Scholar] [CrossRef] [PubMed]
[23] Beurel, E., Grieco, S.F. and Jope, R.S. (2015) Glycogen Synthase Kinase-3 (GSK3): Regulation, Actions, and Diseases. Pharmacology & Therapeutics, 148, 114-131. [Google Scholar] [CrossRef] [PubMed]
[24] Chuang, D.M., Wang, Z. and Chiu, C.-T. (2011) GSK-3 as a Target for Lithium-Induced Neuroprotection against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke. Frontiers in Molecular Neuroscience, 4, Article 15. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, Q., Liao, Y., Liu, Z., et al. (2021) Interleukin-17 and Ischaemic Stroke. Immunology, 162, 179-193. [Google Scholar] [CrossRef] [PubMed]
[26] 李硕, 王建. 大豆异黄酮临床应用的研究进展[J]. 大豆科学, 2020, 39(4): 633-640.
[27] Zupanic, E., von Euler, M., Winblad, B., et al. (2021) Mortality after Ischemic Stroke in Patients with Alzheimer’s Disease Dementia and Other Dementia Disorders. Journal of Alzheimer’s Disease, 81, 1253-1261. [Google Scholar] [CrossRef
[28] Zaorsky, N.G., Zhang, Y., Tchelebi, L.T., et al. (2019) Stroke among Cancer Patients. Nature Communications, 10, Article No. 5172. [Google Scholar] [CrossRef] [PubMed]